The time it takes for the US Food and Drug Administration to review 510(k) applications for clearing medical devices has increased because of industry's failure to file submissions of an adequate quality, an internal analysis by the FDA has revealed1.
In addition, the FDA points out that the number of additional information (AI) letters per submission that the agency sends to a company identifying questions they need to address – which are called cycles – has increased...
Please Login to read the full article.
